Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 1/2 11Phase 1 10Phase 3 4Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2

Conditions

Multiple Myeloma 2Lymphoma, Non-Hodgkin 2

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × plerixafor × Clear all
NCT01146834 2019-12-27

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Weill Medical College of Cornell University

Phase 3 Completed
47 enrolled 12 charts
Plasma cell

Multiple Myeloma

NCT01767714 2014-12-09

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Sanofi

Phase 3 Completed
100 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00103610 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

Sanofi

Phase 3 Completed
298 enrolled 16 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00103662 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Sanofi

Phase 3 Completed
302 enrolled 17 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡